Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 20 Source: CRO
- €4.1 billion turnover
-
-€121.6 million
profit - 11,500 employees
-
31st Dec 19 Source: CRO
- €4.4 billion turnover
-
€154.4 million
profit - 10,400 employees
- 6 more years available »
Ranking
By Turnover
(€4.1 billion)- 30th in Top Companies
- 7th in Health
- 5th in Pharma
By Employees
(11,500)- 19th in Top Companies
- 4th in Health
- 3rd in Pharma
-
- 11,500
- €4.1 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- May 08 Bank of Ireland paves way for negative rates on accounts with over €1m
- May 08 Air Corps bid for search and rescue services would result in job losses, union warns
- May 08 FBD, ICG and Uniphar under fire over executive pay
- May 07 US jobs growth slows despite reopenings and vaccinations
- May 07 Regulator expects FBD to pay ‘all reasonable costs’ of publicans, court told